AdvancedEducational map · not a treatment protocol

Perimenopause & Menopause Optimization

Kisspeptin, Epitalon, MOTS-c, and PT-141 as they show up next to menopause folklore. Not HRT and not a vasomotor-symptom indication.

Duration

12-week cycles

First reports

2-4 weeks

SKUs on this map

4

1Overview

This is not HRT and not a vasomotor-symptom indication. Vyleesi is labeled HSDD in premenopausal women; menopause is a different file. Kisspeptin, Epitalon, and MOTS-c next to hot flashes is folklore. Severe symptoms still belong with gynecology or endocrinology.

Ideal Candidates

✓Women mapping these SKUs next to perimenopause folklore, not as a hot-flash NDA
✓Readers comparing Vyleesi HSDD labeling to menopause off-label use
✓Anyone already on or considering HRT who needs peptides named as adjuncts, not replacements

Contraindications

✕Active estrogen-receptor sensitive cancers
✕Undiagnosed abnormal vaginal bleeding

2The Science

Ovarian estrogen falls. That is not a peptide deficiency. Kisspeptin is GnRH biology. Epitalon is pineal folklore. MOTS-c is AMPK mechanism. PT-141 is an HSDD label in a different population. None of these replaces indicated HRT or treats hot flashes as an NDA.

3The Peptide Stack

KI

Kisspeptin

View Profile →

GnRH-axis peptide. Hot-flash relief is a hypothesis, not a labeled indication.

Mechanism: Regulates GnRH pulse frequency in the hypothalamus.

Half-life: ~28 minutesDose range: 100-500 mcg/dose
EP

Epitalon

View Profile →

Pineal tetrapeptide folklore for sleep. Not a menopause insomnia NDA.

Mechanism: Stimulates the pineal gland to produce melatonin and normalizes cortisol rhythms.

Half-life: ~2-4 hours (estimated)Dose range: 5-10 mg/day
MO

MOTS-c

View Profile →

Mitochondrial AMPK paper trail. Not an estrogen-loss fat-gain protocol.

Mechanism: Mitochondrial-derived peptide that upregulates AMPK, improving cellular energy metabolism.

Half-life: ~4-6 hours (estimated)Dose range: 5-10 mg/week
PT

PT-141

View Profile →

Vyleesi is labeled HSDD in premenopausal women. Menopause use is off-label. Compounded cakes are not Vyleesi.

Mechanism: Agonist at the melanocortin receptors (MC3R and MC4R) in the central nervous system.

Half-life: ~2.7 hoursDose range: 500-2000 mcg

4Protocol Tiers

SKU Map Next to Menopause Folklore

Four leaves people search together. Complementary marketing is not a combination trial and not HRT.

Duration
10-12 weeks
Frequency: Daily & Weekly specific
Kisspeptin100-200 mcg
Timing: Evening administration
Clinical Note: Observe carefully for changes in hot flash frequency.
Epitalon1mg
Timing: Nightly before bed
Clinical Note: Run for 10-20 days max per cycle.
MOTS-c5mg
Timing: Once a week, ideally pre-workout
Clinical Note: Ensure proper methylation support (B-vitamins) when using MOTS-c.
PT-1411-2mg
Timing: As needed, 2-4 hours prior to intimate activity
Clinical Note: May cause flushing or mild nausea initially. Start at 1mg.

5Lifestyle Integration

Lifestyle notes that travel with these SKUs. Not a prescription and not required for the math to be valid.

Training

Resistance training is still training. This page is not an osteoporosis or menopause-hormone protocol.

Nutrition

Supplement Stack: DIM (Diindolylmethane) for proper estrogen metabolism, Maca Root for hormonal balance, Magnesium Glycinate (400mg) for sleep, and Black Cohosh for vasomotor symptoms. Prioritize high dietary calcium and Vitamin D3/K2.

Sleep

Epitalon + Magnesium Glycinate will drastically improve sleep, but keep the bedroom exceptionally cool (65°F) to combat night sweats.

Stress Management

Prioritize parasympathetic activation via Ashwagandha or L-Theanine; the adrenal glands must take over some hormone production as the ovaries retire.

6Timeline & Expectations

Weeks 1-2

What You'll NoticeSleep and vasomotor changes, if any, are not a pineal-reset trial endpoint. Track symptoms; do not skip indicated care.
What's Happening BiologicallyPineal gland resetting and neurological signaling in the hypothalamus stabilizing.

Weeks 3-6

What You'll NoticeEnergy and libido reports mix placebo, sleep, and off-label PT-141. MOTS-c is not a menopause metabolic NDA.
What's Happening BiologicallyMitochondrial biogenesis and sustained hypothalamic-pituitary stabilization.

7Monitoring & Safety

Key Metrics to Track

DEXA ScanMonitor bone mineral density (BMD) annually to detect osteopenia early.
Hormone Panel + ThyroidTrack Estradiol, FSH, LH, Free Testosterone, and a full Thyroid panel.

Troubleshooting

Nausea from PT-141
Possible Causes
  • Dose too high for initial tolerance
Solutions
  • Lower the PT-141 dose to 1mg or less. Consider taking an anti-nausea ginger supplement beforehand.
Symptoms remain severe despite stack
Possible Causes
  • Peptides + Supplements alone may not be sufficient for severe hormonal depletion
Solutions
  • Consult with a functional endocrinologist regarding BHRT (Bioidentical Hormone Replacement Therapy) as an adjunct.